Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
Multi-modal neuroimaging and cognitive assessment of females with multiple sclerosis across different stages of menopause
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 2, 2024
The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing the Efficacy of Triplet Versus Doublet Chemotherapy to Achieve Clinical Complete Response in Patients with Locally Advanced Rectal Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 3, 2024
Pain Reduction Using NEurostimulation (PRUNE) Study
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 8, 2024
Diet and Meal Timing in Patients with Non-Alcoholic Fatty Liver Disease: A Pilot Study
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 10, 2024
Pilot/feasibility study of pulmonary nodules and coronary calcification screening at standard Computed Tomography simulation for breast cancer radiotherapy (Screening from CT Simulation, SCTS)
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 17, 2024
Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 23, 2024
A Phase 1b, Open Label, Multi-Center, Dose Optimization and Dose Expansion Study to Assess the Safety and Efficacy of DFV890 in Adult Patients With Myeloid Diseases
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 29, 2024
Prospective Evaluation of Nivolumab in Adjuvant Esophageal Carcinoma/Gastroesophageal Junction Cancer: A Non-interventional Study
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 29, 2024
A Phase 1/1b Dose Escalation and Cohort Expansion Study of MGC018 in Combination with MGD019 in Participants with Advanced Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 7, 2024
A Phase II Trial of Tazemetostat Plus Mosunetuzumab In Untreated Follicular Lymphoma
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 7, 2024